Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Sema4 Holdings Corp. SMFR
$0.31
-$0.07 (-22.37%)
На 18:04, 12 мая 2023
+651.61%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
246372572.00000000
-
week52high
4.09
-
week52low
0.22
-
Revenue
234694000
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
13 мар 2023 г. в 10:59
Описание компании
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BTIG | Buy | Buy | 18 авг 2022 г. |
| Jefferies | Hold | Buy | 16 авг 2022 г. |
| Cowen & Co. | Outperform | Outperform | 16 мая 2022 г. |
| Goldman Sachs | Buy | 19 ноя 2021 г. | |
| BTIG | Buy | 08 окт 2021 г. | |
| Cowen & Co. | Outperform | Outperform | 15 ноя 2022 г. |
| Goldman Sachs | Neutral | Buy | 07 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| White Karen Ann | D | 20204 | 2241 | 26 янв 2023 г. |
| White Karen Ann | D | 45039 | 4503 | 25 янв 2023 г. |
| White Karen Ann | A | 22445 | 4503 | 25 янв 2023 г. |
| Saad Kareem | D | 113487 | 6292 | 20 янв 2023 г. |
| Saad Kareem | D | 144116 | 18014 | 19 янв 2023 г. |
| Saad Kareem | A | 119779 | 18014 | 19 янв 2023 г. |
| Saad Kareem | D | 101765 | 3170 | 04 янв 2023 г. |
| White Karen Ann | D | 17942 | 1630 | 04 янв 2023 г. |
| White Karen Ann | D | 45864 | 3276 | 01 янв 2023 г. |
| White Karen Ann | A | 19572 | 3276 | 01 янв 2023 г. |
Новостная лента
Sema4: Restructuring Plan Figures Don't Add Up
Seeking Alpha
22 дек 2022 г. в 22:29
Sema4's restructuring plan has a number of potential downsides that could affect the company's cash position in the coming few quarters. The booting of the CEO signals the start of a strategic focus on short-term survival away from long-term growth.
Sema4 Holdings Corporation (SMFR) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 22:46
Sema4 Holdings Corporation (NASDAQ:SMFR ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Joel Kaufman - VP, Finance & Corporate Development Katherine Stueland - CEO & Director Kevin Feeley - SVP, Operations & CFO Conference Call Participants Mark Massaro - BTIG David Delahunt - Goldman Sachs Operator Welcome to the Sema4 Third Quarter 2022 Earnings Conference Call. My name is Cheryl, and I will be your operator for today's call.
Why Sema4 Holdings Stock Is Crashing Today
The Motley Fool
16 авг 2022 г. в 11:32
The healthcare company delivered plenty of bad news in its Q2 update.
Sema4 Holdings Corp (SMFR) CEO Katherine Stueland on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
15 авг 2022 г. в 21:29
Sema4 Holdings Corp (NASDAQ:SMFR ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Joel Kaufman - VP, Finance & Corporate Development Katherine Stueland - CEO & Director Kevin Feeley - SVP, Operations and Head of GeneDx Conference Call Participants David Delahunt - Goldman Sachs Group Matt Kim - Jeffrey Max Masucci - Cowen and Company Mark Massaro - BTIG Operator Good day, and thank you for standing by. Welcome to the Sema4 Second Quarter 2022 Earnings Conference Call.
Sema4 Holdings, Big Data For Precision Medicine Solutions
Seeking Alpha
18 июл 2022 г. в 12:02
Big data and machine learning are booming also in healthcare, where it enables precision medicine and population health platform services. Sema4 Holdings has amassed huge amounts of medical data and a sophisticated platform in order to extract valuable insight from these for health systems, pharma companies and individuals.